Table 5.
Clinical and pathological features of the gastric cancer patients showing both HER2-positive and MSI status.
| Features | HER2-Positive and MSI (n = 2) | |
|---|---|---|
| Case 1 | Case 2 | |
| Age | 76 | 74 |
| Sex | Female | Male |
| Location | Antrum | Antrum |
| Histological type | Intestinal | Intestinal |
| Pathological diagnosis | Adenocarcinoma | Adenocarcinoma |
| Degree of differentiation | G3 | G3 |
| T | T3 | T3 |
| N | N3a | N0 |
| M | M1 | M0 |
| Stage | IV | IIA |
| Lymphatic involvement | Yes | Yes |
| Vascular involvement | Yes | Yes |
| Perineural involvement | Yes | Yes |
| Adjuvant chemotherapy | No | No |
| Survival | Deceased | Deceased |
HER2: Human Epidermal Growth Receptor 2, MSI: Microsatellite instability.